Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2016-03-25 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
160325 - Procuration Assemblée Générale 28 avril 2016_final.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "PROCURATION POUR L'ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES DU 28 AVRIL 2016 À 11 HEURES" (Proxy for the General Shareholders' Meeting of April 28, 2016). It is a form for shareholders to appoint a proxy to vote on various resolutions concerning the approval of annual accounts, remuneration reports, director appointments, and capital authorization renewals, which are all typical items on an Annual General Meeting (AGM) agenda. The structure, the request for voting instructions (Pour/Contre/Abstention), and the reference to the Ordinary and Extraordinary General Meeting confirm this is material related to the AGM. Therefore, the appropriate classification is AGM-R (AGM Information).
2016-03-25 French
Jaarverslag 2015.pdf
Annual Report Classification · 100% confidence The document is a comprehensive annual report for UCB, containing a letter to stakeholders, management reports, consolidated financial statements, and detailed performance reviews for the fiscal year 2015. It is clearly a full annual report rather than an announcement or a summary, as evidenced by the table of contents and the depth of the content provided. FY 2015
2016-03-25 Dutch
Report of the Statutory Auditor on the 2015 annual accounts UCB SA.pdf
Audit Report / Information Classification · 99% confidence The document is explicitly titled 'Statutory auditor's report to the general shareholders' meeting on the annual accounts for the year ended 31 December 2015'. It contains an 'Unqualified Opinion' on the annual accounts and details the auditor's responsibilities and findings, which is the core content of an Audit Report. Although it relates to the annual accounts (which might suggest a 10-K), the document itself is the formal report issued by the external auditor, making 'Audit Report / Information' (AR) the most precise classification. It is not the full Annual Report (10-K) but the specific audit opinion accompanying it. FY 2015
2016-03-25 English
160225 UCB SA - Annual accounts_FR (final).pdf
Annual Report Classification · 95% confidence The document is a formal Belgian 'Comptes Annuels' (Annual Accounts) filing for UCB SA. It includes the company's identification details, a list of directors and auditors, and a balance sheet ('Bilan après répartition') for the fiscal year 2015. This constitutes the official annual financial reporting required by law, which aligns with the 10-K category for comprehensive yearly financial performance reporting. FY 2015
2016-03-25 French
Verslag van de Commissaris over de jaarrekening 2015 UCB NV.pdf
Audit Report / Information Classification · 99% confidence The document is titled "Verslag van de commissaris aan de algemene vergadering van aandeelhouders over de jaarrekening voor het boekjaar afgesloten op 31 december 2015" (Report of the statutory auditor to the general meeting of shareholders on the annual accounts for the financial year ended December 31, 2015). This text explicitly contains the formal opinion (Oordeel zonder voorbehoud) from the auditor (PwC) regarding the annual financial statements. While it is a report *about* the annual accounts, the content is the actual audit opinion and related statutory checks, which falls under the scope of an Audit Report/Information (AR) rather than the full Annual Report (10-K) or just an announcement of the report (RPA). The presence of detailed auditor responsibilities, scope of work, and the final opinion strongly points to an Audit Report. FY 2015
2016-03-25 Dutch
160325 Special report by the Board to the shareholders_final signed.pdf
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled "SPECIAL REPORT BY THE BOARD OF DIRECTORS TO THE SHAREHOLDERS on the use and purpose of the authorized capital prepared in accordance with article 604 of the Belgian Companies Code". This document details the proposal to renew the Board's powers regarding the authorized capital, which involves the potential issuance of shares, convertible bonds, or warrants. This directly relates to the company's capital structure and financing authorization, which falls under the 'Capital/Financing Update' category (CAP). While it is a report, its specific focus on authorizing capital increases aligns best with CAP rather than a general Annual Report (10-K) or a simple Dividend Notice (DIV). It is a formal report presented to shareholders regarding capital management powers.
2016-03-25 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.